$74.85 0.8 1.1%
Last Trade - 25/01/21
| Market Cap | £26.87bn |
| Enterprise Value | £29.09bn |
| Revenue | £4.97bn |
| Position in Universe | 330th / 6623 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 0.000 | 6,596 | 6,792 | 7,153 | 7,508 | 6,767 | 7,775 | +4.4% | ||
| +86.7 | ||||||||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Alcon AG is a Switzerland-based company specialized in the medical industry. The Company operates mainly as an eye care device company. Alcon AG reports its activities into two segments: Surgical and Vision Care. The surgical segment provides a line of ophthalmic surgical products that enable surgeons to achieve accurate results. Its surgical portfolio includes technologies and devices for cataract, retinal, refractive surgery, as well as advanced technology intraocular lenses (ATIOLs) to treat cataracts and refractive errors, such as presbyopia and astigmatism. The surgical segment also includes advanced viscoelastics, surgical solutions, surgical packs and other disposable products for cataract and vitreoretinal surgery. The Vision Care segment manufactures contact lenses and lens care products, such as products for dry eye, contact lens care, ocular allergies, as well as ocular vitamins and redness relievers. The Company also offers continuing education for eye care professionals.
| Last Annual | December 31st, 2019 |
| Last Interim | September 30th, 2020 |
| Incorporated | September 21, 2018 |
| Public Since | April 9, 2019 |
| No. of Shareholders: | n/a |
| No. of Employees: | 22,142 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | New York Stock Exchange (Dual Listing) |
| Shares in Issue | 497,200,000 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | Rue Louis-d'Affry 6, FRIBOURG, 1701, Switzerland |
| Web | https://www.alcon.com/ |
| Phone | + |
| Contact | Karen King (SVP, Head of Global Investor Relations and Corporate Communications) |
| Auditors | PricewaterhouseCoopers LLP |
As of 25/01/21, shares in Alcon AG are trading at $74.85, giving the company a market capitalisation of £26.87bn. This share price information is delayed by 15 minutes.
Shares in Alcon AG are currently trading at $74.85 and the price has moved by 19.91% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Alcon AG price has moved by 2.55% over the past year.
There are no analysts currently covering Alcon AG.
Alcon AG is scheduled to issue upcoming financial results on the following dates:
Alcon AG does not currently pay a dividend.
Alcon AG does not currently pay a dividend.
Alcon AG does not currently pay a dividend.
To buy shares in Alcon AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Alcon AG are currently trading at $74.85, giving the company a market capitalisation of £26.87bn.
Here are the trading details for Alcon AG:
Based on an overall assessment of its quality, value and momentum, Alcon AG is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Alcon AG are currently priced at $74.85. At that level they are trading at 0.2% discount to the analyst consensus target price of 0.00.
Analysts covering Alcon AG currently have a consensus Earnings Per Share (EPS) forecast of 1.0128855626 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Alcon AG. Over the past six months, the relative strength of its shares against the market has been 4.13%. At the current price of $74.85, shares in Alcon AG are trading at 22.81% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Alcon AG.
Alcon AG's management team is headed by:
Here are the top five shareholders of Alcon AG based on the size of their shareholding:
